Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Azacitidine, sold under the brand name Vidaza among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia. It is a chemical analog of cytidine, a nucleoside in DNA and RNA.[medical citation needed] Azacitidine and its deoxy derivative, decitabine (also known as…
Applications & Research
Explore the main themes, entities and connections around Azacitidine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
dna patients treatment also leukemia rna juvenile myelomonocytic methylation may myelodysplastic syndrome effects cell used inhibition toxicity medical cytidine decitabine
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Azacitidine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Azacitidine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Azacitidine | ATC code | L01BC07 (WHO) | 1.00 | infobox |
| Azacitidine | CAS Number | 320-67-2 Y | 1.00 | infobox |
| Azacitidine | ChEBI | CHEBI:2038 Y | 1.00 | infobox |
| Azacitidine | ChEMBL | ChEMBL1489 Y | 1.00 | infobox |
| Azacitidine | ChemSpider | 9072 Y | 1.00 | infobox |
| Azacitidine | CompTox Dashboard (EPA) | DTXSID9020116 | 1.00 | infobox |
| Azacitidine | DrugBank | DB00928 Y | 1.00 | infobox |
| Azacitidine | ECHA InfoCard | 100.005.711 | 1.00 | infobox |
| Azacitidine | Elimination half-life | 4 hr. | 1.00 | infobox |
| Azacitidine | Formula | C8H12N4O5 | 1.00 | infobox |
| Azacitidine | IUPHAR/BPS | 6796 | 1.00 | infobox |
| Azacitidine | KEGG | D03021 Y | 1.00 | infobox |
| Azacitidine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Azacitidine | Legal status | CA: ℞-only | 1.00 | infobox |
| Azacitidine | Legal status | US: ℞-only | 1.00 | infobox |
| Azacitidine | Legal status | EU: Rx-only | 1.00 | infobox |
| Azacitidine | License data | US DailyMed: Azacitidine | 1.00 | infobox |
| Azacitidine | MedlinePlus | a607068 | 1.00 | infobox |
| Azacitidine | Molar mass | 244.207 g·mol−1 | 1.00 | infobox |
| Azacitidine | Other names | 5-Azacytidine, Azacytidine, Ladakamycin, 4-Amino-1-β-D-ribofuranosyl-s-triazin-2(1H)-one, U-18496, CC-486 | 1.00 | infobox |
| Azacitidine | Pregnancy category | AU: X (High risk) | 1.00 | infobox |
| Azacitidine | PubChem CID | 9444 | 1.00 | infobox |
| Azacitidine | Routes of administration | Subcutaneous, intravenous, by mouth | 1.00 | infobox |
| Azacitidine | Trade names | Vidaza, Azadine, Onureg | 1.00 | infobox |
| Azacitidine | UNII | M801H13NRU | 1.00 | infobox |
| Azacitidine | is a | ribonucleoside | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.